Radioactive iodine-125 (I-125) is the most widely used radioactive sealed source for
interstitial permanent brachytherapy (BT). BT has the exceptional ability to deliver extremely …

Abstract Background and Purpose High dose-rate (HDR) brachytherapy as a monotherapy
is an accepted treatment for localized prostate cancer, but the optimal dose and fractionation …

PURPOSE The purpose of this guideline is to present evidence-based consensus
recommendations for low dose rate (LDR) permanent seed brachytherapy for the primary …

Purpose Using the primary endpoint of time to biochemical progression (TTP), Androgen
Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy …

Background and purpose The optimal dose for prostate stereotactic body radiotherapy
(SBRT) is still unknown. This study evaluated the dose–response relationships for prostate …

Prostate brachytherapy techniques are described, concerning both permanent seed implant
and high dose rate brachytherapy. The following guidelines are presented: brachytherapy …

Background We compared the oncological outcomes of patients who received seed
brachytherapy (SEED-BT) with those who received radical prostatectomy (RP) for …

Background and purpose Quantifying the interobserver variability (IoV) of prostate and
periprostatic anatomy delineation on prostate MRI is necessary to inform its use for treatment …

Introduction and objectives We previously published the toxicity and initial results of a
prospective cohort of patients treated with 2 fractions HDR-BRT administered in a single …

Purpose Previous studies have demonstrated excellent overall outcomes in patients who
underwent low-dose-rate brachytherapy (LDR-BT) in intermediate-risk, localized prostate …